BlackRock Investment Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
BA
BIT
BFA
BlackRock Investment Management's DGX Position: Q4 2016 in Review
BlackRock Investment Management reduced its Quest Diagnostics (DGX) stake by 4.6% in Q4 2016, selling an estimated $6.05M and leaving 1,469,719 shares worth $135M. The position accounts for 0.16% of the portfolio, ranked #132.
BlackRock Investment Management first reported a position in DGX in Q2 2013 and has held it in 15 quarters since. The position peaked at $156M in Q2 2015. 598 funds tracked by Wall St. Rank hold DGX as of Q4 2016.
- BlackRock Investment Management held 1,469,719 shares of Quest Diagnostics worth $135M as of Q4 2016.
- BlackRock Investment Management sold 70,172 Quest Diagnostics shares in Q4 2016, an estimated $6.05M.
- Quest Diagnostics made up 0.16% of BlackRock Investment Management's portfolio in Q4 2016, its #132 holding.
- BlackRock Investment Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 15 quarters since.
- BlackRock Investment Management's Quest Diagnostics position peaked at $156M in Q2 2015.
- 598 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.
Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.